Blood vessels are formed during development and tissue repair through a plethora of modifiers that coordinate efficient vessel assembly in various cellular settings. Here we used the yeast 2‐hybrid approach and demonstrated a broad affinity of connective tissue growth factor (CCN2/CTGF) to C‐terminal cystine knot motifs present in key angiogenic regulators Slit3, von Willebrand factor, platelet‐derived growth factor‐B, and VEGF‐A. Biochemical characterization and histological analysis showed close association of CCN2/CTGF with these regulators in murine angiogenesis models: normal retinal development, oxygen‐induced retinopathy (OIR), and Lewis lung carcinomas. CCN2/CTGF and Slit3 proteins worked in concert to promote in vitro angiogenesis and downstream Cdc42 activation. A fragment corresponding to the first three modules of CCN2/CTGF retained this broad binding ability and gained a dominant‐negative function. Intravitreal injection of this mutant caused a significant reduction in vascular obliteration and retinal neovascularization vs . saline injection in the OIR model. Knocking down CCN2/CTGF expression by short‐hairpin RNA or ectopic expression of this mutant greatly decreased tumorigenesis and angiogenesis. These results provided mechanistic insight into the angiogenic action of CCN2/CTGF and demonstrated the therapeutic potential of dominant‐negative CCN2/CTGF mutants for antiangiogenesis.—Pi, L., Shenoy, A. K., Liu, J., Kim, S., Nelson, N., Xia, H., Hauswirth, W. W., Petersen, B. E., Schultz, G. S., Scott, E. W. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J. 26, 3365–3379 (2012). www.fasebj.org